SANTA FE, NM / ACCESSWIRE / February 10, 2022 / Sigma Labs, Inc. (NASDAQ: SGLB) (the "Company"), a leading developer of quality assurance software to the commercial 3D printing industry, announced today that the Company's warrants to purchase common stock issued on February 21, 2017 (NASDAQ: SGLBW) (the "Warrants") will expire in accordance with their terms as of 5:00 p.m. EST, on February 22, 2022. The Company is informed by the Nasdaq Stock Market LLC ("Nasdaq") that trading of the Warrants on Nasdaq will be suspended on February 17, 2022. The exercise price for one share of the Company's common stock under the Warrants is $40.00. On February 9, 2022, the last reported sale price of the Company's common stock was $2.42 per share.
The Company also is informed that Nasdaq intends to file a Form 25 on behalf of the Company with the Securities and Exchange Commission on February 17, 2022 to effect the delisting of the Warrants from Nasdaq and the deregistration of the Warrants under Section 12(b) of the Securities Exchange Act of 1934, as amended.
The listing of the Company's common stock (NASDAQ: SGLB) will not be affected by the expiration and delisting of the Warrants.
About Sigma Labs
Sigma Labs Inc. is a leading provider of in-process quality assurance (IPQA") software to the additive manufacturing industry. Sigma Labs specializes in the development and commercialization of real-time monitoring and analytics solutions known as PrintRite3D for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost-savings and production efficiencies. Sigma Labs believes its software product will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information, please visit www.sigmalabsinc.com.
Contacts:
Investor Contact: Chris TysonExecutive Vice President MZ Group - MZ North America949-491-8235SGLB@mzgroup.uswww.mzgroup.us
Company Contact:Steven GerstenSigma Internal IR813-334-9745investors@sigmalabsinc.com
SOURCE: Sigma Labs, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。